Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norethindrone Acetate for Bleeding with Etonogestrel Implant
NCT02353247Completed
- Sponsor
- Norton Healthcare
- Start
- Aug 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of norethisterone acetate in abnormal uterine bleeding (AUB) (2 arms), sponsored by Norton Healthcare. Primary endpoint: Impact of Aygestin on the Management of Bothersome Bleeding Associated With the Etonogestrel Contraceptive Implant at 9 months. Started Aug 2015; status: completed.
02
Drugs
norethisterone acetate
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT02353247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353247.